Management of multiple sclerosis
Management of multiple sclerosis in adolescents – current treatment options and related adherence issues
... Abstract: Multiple sclerosis (MS) is a progressive inflammatory demyelinating disorder of the central nervous system that is increasingly recognized in children and ...on management strategies ...
13
Assessing cost-effectiveness in the management of multiple sclerosis
... were: Multiple Sclerosis, Disease management, Immunomodulatory drugs, Cost- Effectiveness, Cost-Effectiveness Analysis, Quality of life, Eco- nomic Evaluation, Cost Analysis, Cost benefit, ...
18
Optimization models on management of multiple sclerosis
... optimal management of Multiple Sclerosis (MS) based on The proposed problems deal with the objectives of of MS, maximizing the expected size of oligodendrocytes and minimizing the variance of ...
6
Optimal management of multiple sclerosis during pregnancy: current perspectives
... Abstract: Multiple sclerosis (MS) is a common inflammatory demyelinating disorder of the central nervous ...the management of MS, particularly with respect to counseling and drug ...
10
Patient considerations in the management of multiple sclerosis: development and clinical utility of oral agents
... making multiple choices that define them as individuals, often not realizing that decisions are being made by them and for them on a continuous ...the multiple sclerosis (MS) world, when it comes to ...
8
HEALTHCARE MANAGEMENT AND PSYCHOLOGICAL WELL-BEING IN PATIENTS WITH MULTIPLE SCLEROSIS AND THEIR PRIMARY CAREGIVERS
... healthcare management and psychological well-being of both the patients and their primary ...200 Multiple Sclerosis (MS) patients and 200 primary caregiver’s in ...
9
Eye disorders in patients with multiple sclerosis: natural history and management
... Abstract: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system and leading cause of disability in young adults. Vision impairment is a common component of disability for this ...
14
Development of oral immunomodulatory agents in the management of multiple sclerosis
... Relapsing Multiple Sclerosis) is a further randomized, parallel-group, single-blind study comparing the effectiveness and safety of the two doses of teriflunomide (7 and 14 mg) versus IFN- β 1a 44 µ g three ...
20
Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations
... 125. Nixon R, Capkun-Niggli G, Bergvall N, Dias S. Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of ...
12
Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate
... a medication used in Europe for the treatment of psoriasis. The unique mechanism of action of DMF remains under evaluation; however, it has been shown to act through multiple pathways leading to shifts away from ...
12
Role of oral teriflunomide in the management of multiple sclerosis
... relapsing–remitting multiple sclerosis is changing ...relapsing–remitting multiple sclerosis, while others have completed Phase III trials and are awaiting review for ...relapsing–remitting ...
15
New approaches in the management of multiple sclerosis
... illnesses. Multiple Sclerosis Quality of Life Inventory, Multiple Sclerosis Quality of Life-54, Functional Assessment of Multiple Sclerosis, Leeds Multiple ...
24
A REVIEW ON CLINICAL MANAGEMENT OF MULTIPLE SCLEROSIS
... Multiple sclerosis affects the ability of nerve cells in the brain and spinal cord to communicate with each ...In Multiple sclerosis, the body own immune system attacks and damages the ...
11
Navigating choice in multiple sclerosis management
... 19. Kalincik, T., Manouchehrinia, A., Sobisek, L., Jokubaitis, V., Spelman, T., Horakova, D., Havrdova, E., Trojano, M., Izquierdo, G., Lugaresi, A., Girard, M., Prat, A., Duquette, P., Grammond, P., Sola, P., Hupperts, ...
8
A systematic review of the effectiveness of self-management interventions in people with multiple sclerosis at improving depression, anxiety and quality of life
... We purposefully reported on the final follow-up assessment following SMI, as there is some evidence that psychological benefits may not always present immediately following an inter- vention [38]. Furthermore, ...
17
Randomized controlled trial of a teleconference fatigue management plus physical activity intervention in adults with multiple sclerosis: rationale and research protocol
... Secondary dependent variables Health-related quality of life, mental health, and participation in life roles will be measured with the SF-12, Mental Health Inventory, and Community Participation Indicator (CPI), respect- ...
8
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids
... Abstract: Cannabinoids such as Cannabis-based medicinal extracts (CBMEs) are increasingly being used in the treatment of spasticity associated with multiple sclerosis (MS). They have been shown to have a ...
5
Depressive disorder in patients with multiple sclerosis
... with multiple sclerosis assessed in this study is in line with other ...and management of psychiatric disorders in individuals with multiple ...with multiple sclerosis varies ...
5
Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self efficacy, quality of life, anxiety and depression 1 year later
... The Can Do treatment aims to uncover and promote existing capabilities, with the notion ‘stressor’ as central concept. The treatment is primarily a sociologically ori- ented approach. It tries to identify stressors that ...
8
Vol 33, No 1 (2020)
... MRI accuracy in detecting MS plaques and in differ- entiating these from other mimickers depends on the MR protocols and specific technical parameters. This is even more critical for monitoring response to therapy and ...
10